Received Jun 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RAB | RABIES (RABAVERT) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | FDP00555 | IM |
The patient received only one dose of RabAvert on 14-Nov-2024; Case reference number US-BN-2025-000422 is a spontaneous case initially received from pharmacist via Med Communication (reference number: USBAV25-0738) on 02-Apr-2025 and concerns a female patient of unspecified age. The patient's medical history and concomitant medication details were not provided. On 14-Nov-2024 (also reported as 14-Nov-2025), the patient took first dose of RabAvert along with its constituent parts prefilled syringe, needle for injection and needle for reconstitution (batch number: FDP00555; expiration date: 01-Sep-2027) at an unknown dose, intramuscularly at unknown site of administration for indication pre-exposure for school. As reported, the patient received only one dose of RabAvert and now she wanted to see if she can finish the series or if she needs to start over (explicitly coded as 'incomplete course of vaccination'). At the time of initial report, it was unknown if the patient experienced any adverse event due to RabAvert. No further information was provided.; Reporter's Comments: A female patient of unknown age/age group had received RabAvert vaccine for pre-exposure for school. As reported, patient had received only the first dose of RabAvert vaccine which is considered as incomplete course of vaccination. It was unknown if patient experienced any adverse events due to RabAvert vaccine. Incomplete course of vaccination is considered as listed as per company convention. The patient's medical history and concomitant medication details were not provided. Event incomplete course of vaccination is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A female patient of unknown age/age group had received RabAvert vaccine for pre-exposure for school. As reported, patient had received only the first dose of RabAvert vaccine which is considered as incomplete course of vaccination. It was unknown if patient experienced any adverse events due to RabAvert vaccine. Incomplete course of vaccination is considered as listed as per company convention. The patient's medical history and concomitant medication details were not provided. Event incomplete course of vaccination is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None